2018
DOI: 10.1016/j.cca.2017.11.023
|View full text |Cite
|
Sign up to set email alerts
|

Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
15
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(19 citation statements)
references
References 30 publications
2
15
2
Order By: Relevance
“…This assessment demonstrated that obesity increased risk of dyslipidemia by 64% in metabolically healthy adults, however, obesity increased risk of diabetes by 240% in metabolically healthy adults (Fingeret et al, 2018). T2DM patients with obesity had higher fetuin-A levels as compared to non-obese patients and obese glucose tolerance (NGT) subjects (p < 0.001) (Zhou et al, 2018). The miR-144 was one of the highly upregulated miRNAs that showed a linear increase in expression with increasing glycaemic status.…”
Section: Discussionmentioning
confidence: 98%
“…This assessment demonstrated that obesity increased risk of dyslipidemia by 64% in metabolically healthy adults, however, obesity increased risk of diabetes by 240% in metabolically healthy adults (Fingeret et al, 2018). T2DM patients with obesity had higher fetuin-A levels as compared to non-obese patients and obese glucose tolerance (NGT) subjects (p < 0.001) (Zhou et al, 2018). The miR-144 was one of the highly upregulated miRNAs that showed a linear increase in expression with increasing glycaemic status.…”
Section: Discussionmentioning
confidence: 98%
“…The incidence of diabetes mellitus (DM), a common chronic disease in clinical practice that affected over 100 million people in China, is increasing each year (1). It has been reported that DM is a persistent metabolic disorder, which can be induced by hypoglycemia and impaired glucose tolerance due to insulin deficiency and resistance (2,3). Type 1 DM is caused by the reduction of insulin due to the destruction of islet cells and accounts for a minority of patients with DM (4,5).…”
Section: Introductionmentioning
confidence: 99%
“…This hepatokin has many different functions due to its complex structure and its binding to different toll-like receptors (TLR) in different tissues [5]. Studies have reported that TLR4 is associated with obesity-related in ammation and insulin resistance, and fetuin-A acts as the endogenous ligand of TLR4 [6,7,8]. It also reduces the insulin response in muscle and adipose tissue by inhibiting the autophosphorylation of the insulin receptor [4,9,10].…”
Section: Introductionmentioning
confidence: 99%
“…Fetuin-A is known as one of the mediators of in ammation. In adult studies, fetuin-A is associated with many diseases such as infections, renal diseases, cardiovascular diseases, cirrhosis, cancer, insulin resistance and metabolic syndrome [6,11,12,13]. There are a limited number of children studies [14,15,16,17,18].…”
Section: Introductionmentioning
confidence: 99%